FSD Pharma Class Top Management

HUGEDelisted Stock  USD 0.09  0  4.56%   
FSD Pharma employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 12 years, averaging almost 1.0 years of service per executive, having 1.0 employees per reported executive. Evaluation of FSD Pharma's management performance can provide insight into the firm performance.
Anthony Durkacz  Chairman
Co-Chairman of the Board
Zeeshan Saeed  President
President Director
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

FSD Pharma Management Team Effectiveness

The company has return on total asset (ROA) of (0.3374) % which means that it has lost $0.3374 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6403) %, meaning that it created substantial loss on money invested by shareholders. FSD Pharma's management efficiency ratios could be used to measure how well FSD Pharma manages its routine affairs as well as how well it operates its assets and liabilities.

FSD Pharma Workforce Comparison

FSD Pharma Class is one of the top stocks in number of employees category among its peers. The total workforce of Information Technology industry is currently estimated at about 64,327. FSD Pharma adds roughly 10.0 in number of employees claiming only tiny portion of equities under Information Technology industry.

FSD Pharma Notable Stakeholders

A FSD Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as FSD Pharma often face trade-offs trying to please all of them. FSD Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting FSD Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dr BPHARMCEO DirectorProfile
Anthony DurkaczCo-Chairman of the BoardProfile
Zeeshan SaeedPresident DirectorProfile
Randell MackPresident BioSciencesProfile
Lakshmi KotraChief IncProfile
Kevin CassidyVice QualityLucidProfile
Donal CPAChief OfficerProfile
Maryann AdessoCorporate SecretaryProfile
Nathan CPAChief OfficerProfile
Andrzej MDVice LucidProfile

About FSD Pharma Management Performance

The success or failure of an entity such as FSD Pharma Class often depends on how effective the management is. FSD Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of FSD management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the FSD management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Please note, the presentation of FSD Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, FSD Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of FSD Pharma's management manipulating its earnings.

FSD Pharma Workforce Analysis

Traditionally, organizations such as FSD Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare FSD Pharma within its industry.

FSD Pharma Manpower Efficiency

Return on FSD Pharma Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.9M
Net Loss Per Executive1.9M
Working Capital Per Employee652K
Working Capital Per Executive652K
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in FSD Stock

If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios